Pharmaceutical Benefits Scheme
GPTKB entity
Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:health_services
|
| gptkbp:administered_by |
gptkb:Australian_Government
|
| gptkbp:aims_to |
reduce out-of-pocket costs for patients
|
| gptkbp:benefits |
Australian residents
|
| gptkbp:covers |
over 2,000 medications
|
| gptkbp:eligibility |
income and health status
|
| gptkbp:established_in |
1948
|
| gptkbp:excludes |
some medications
|
| gptkbp:has_impact_on |
public health
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmaceutical Benefits Scheme
|
| gptkbp:includes |
general and concessional patients
|
| gptkbp:is_accessible_by |
rural populations
|
| gptkbp:is_available_in |
permanent residents
|
| gptkbp:is_challenged_by |
pharmaceutical companies
|
| gptkbp:is_connected_to |
patient outcomes
health outcomes medication adherence healthcare innovation |
| gptkbp:is_considered |
a model for other countries
|
| gptkbp:is_criticized_for |
lack of transparency
bureaucratic processes delays in listing new drugs |
| gptkbp:is_evaluated_by |
healthcare costs
cost-effectiveness patient satisfaction policy analysts economic assessments health economists |
| gptkbp:is_funded_by |
government budget
taxpayer money |
| gptkbp:is_implemented_in |
community pharmacies
|
| gptkbp:is_influenced_by |
gptkb:public_opinion
healthcare trends |
| gptkbp:is_linked_to |
gptkb:healthcare_access
healthcare equity Medicare system |
| gptkbp:is_monitored_by |
gptkb:health_services
|
| gptkbp:is_part_of |
gptkb:Health_Insurance
national health strategy government health policy Australia's healthcare system Australia's universal healthcare system |
| gptkbp:is_prominent_in |
healthcare discussions
|
| gptkbp:is_promoted_by |
non-profit organizations
health advocacy groups |
| gptkbp:is_promoted_through |
public health campaigns
|
| gptkbp:is_reviewed_by |
gptkb:annually
Pharmaceutical Benefits Advisory Committee |
| gptkbp:is_subject_to |
gptkb:political_debates
regulatory changes |
| gptkbp:is_supported_by |
gptkb:pharmaceuticals
gptkb:healthcare_professionals government initiatives research studies |
| gptkbp:is_updated_by |
regularly
|
| gptkbp:is_used_for |
preventive care
|
| gptkbp:is_used_in |
gptkb:guidelines
|
| gptkbp:operates_under |
gptkb:National_Health_Act_1953
|
| gptkbp:provides |
subsidized prescription medications
|
| gptkbp:provides_access_to |
essential medicines
|
| gptkbp:requires |
prescription from a licensed healthcare provider
|
| gptkbp:supports |
chronic disease management
|
| gptkbp:bfsParent |
gptkb:National_Health_Act_1953
|
| gptkbp:bfsLayer |
7
|